STIM
$13.47
Neuronetics
($.07)
(.52%)
STIM
Earnings Whisper ®
N/A
2nd Quarter June 2021
Consensus:  ($0.23)
Revenue:  $14.62 Mil
Tuesday
Aug 3
7:00 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when STIM reports earnings?
Beat
Meet
Miss

Where is STIM's stock price going from here?
Up
Flat
Down
Stock chart of STIM
Analysts
Summary of analysts' recommendations for STIM
Score
Grade
Pivots
Resistance
$14.86
$14.39
$13.96

$13.49

Support
$13.06
$12.59
$12.16
Tweet
Growth
Description
Neuronetics, Inc. is a commercial-stage medical device company. It focused on designing, developing, and marketing products for patients who suffer from psychiatric disorders. NeuroStar Advanced Therapy System(R), is the transcranial magnetic stimulation treatment for depressive disorder. Neuronetics, Inc. is based in Malvern, United States.